Jiang Long

Person

Wayland, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 12,018,017
- Issue date Jun 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,958,879
- Issue date Apr 16, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,834,436
- Issue date Dec 5, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,718,641
- Issue date Aug 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,560,368
- Issue date Jan 24, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as anti-viral agents
- Patent number 11,420,976
- Issue date Aug 23, 2022
- Enanta Pharmaceuticals, Inc.
- Yong He
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,345,699
- Issue date May 31, 2022
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 11,040,998
- Issue date Jun 22, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,008,304
- Issue date May 18, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,988,458
- Issue date Apr 27, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,968,249
- Issue date Apr 6, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparation of sulfonylurea bile acid derivatives
- Patent number 10,947,264
- Issue date Mar 16, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,696,713
- Issue date Jun 30, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,683,279
- Issue date Jun 16, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparation of sulfonylurea bile acid derivatives
- Patent number 10,584,145
- Issue date Mar 10, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,519,191
- Issue date Dec 31, 2019
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR agonists and methods of use thereof
- Patent number 10,472,386
- Issue date Nov 12, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,457,703
- Issue date Oct 29, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,450,301
- Issue date Oct 22, 2019
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Deuterated bile acid derivatives as FXR/TGR5 agonists and methods o...
- Patent number 10,364,267
- Issue date Jul 30, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,253,018
- Issue date Apr 9, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,246,439
- Issue date Apr 2, 2019
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
- Patent number 10,208,081
- Issue date Feb 19, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,149,835
- Issue date Dec 11, 2018
- Elmore Patent Law Group, P.C.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 10,144,729
- Issue date Dec 4, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use therof
- Patent number 10,138,228
- Issue date Nov 27, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,741
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,743
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,742
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclosporin analogues for preventing or treating hepatitis C infection
- Patent number 9,616,099
- Issue date Apr 11, 2017
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20240376079
- Publication date Nov 14, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
- Publication number 20240327452
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240228464
- Publication date Jul 11, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS
- Publication number 20240207224
- Publication date Jun 27, 2024
- Enanta Pharmaceuticals, Inc.
- Jiajun Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20240140984
- Publication date May 2, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240132476
- Publication date Apr 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1...
- Publication number 20230416268
- Publication date Dec 28, 2023
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20230174515
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS...
- Publication number 20230143250
- Publication date May 11, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
- Publication number 20230103494
- Publication date Apr 6, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20220402966
- Publication date Dec 22, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20220356167
- Publication date Nov 10, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20220119366
- Publication date Apr 21, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof
- Publication number 20210261600
- Publication date Aug 26, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS
- Publication number 20210238188
- Publication date Aug 5, 2021
- Enanta Pharmaceuticals, Inc.
- Yong He
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200347092
- Publication date Nov 5, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200331890
- Publication date Oct 22, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
- Publication number 20200270303
- Publication date Aug 27, 2020
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES
- Publication number 20200247839
- Publication date Aug 6, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200157095
- Publication date May 21, 2020
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200109164
- Publication date Apr 9, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20190337923
- Publication date Nov 7, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
- Publication number 20190263860
- Publication date Aug 29, 2019
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20190194245
- Publication date Jun 27, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20180362501
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180362502
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180362503
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180327388
- Publication date Nov 15, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BILE ACID DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20180237471
- Publication date Aug 23, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
- Publication number 20180162905
- Publication date Jun 14, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Heterocyclic compounds as anti-viral agents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Process for preparation of sulfonylurea bile acid derivatives

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Process for preparation of sulfonylurea bile acid derivatives

Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

Bile acid derivatives as FXR agonists and methods of use thereof

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Deuterated bile acid derivatives as FXR/TGR5 agonists and methods o...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole analogs as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use therof

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use thereof

Cyclosporin analogues for preventing or treating hepatitis C infection

Patents Applicationslast 30 patents

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS...

NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof

HETEROCYCLIC COMPOUNDS AS ANTI-VIRAL AGENTS

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

BILE ACID DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS